ArticleCureus2025
Direct Immunofluorescence in Immunobullous Disorders of Skin With Histopathological Correlation Among Patients Attending a Tertiary Care Center.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutoimmune blistering diseases (AIBDs) are a heterogeneous group of disorders characterized by autoantibody-mediated damage to skin and mucous membranes. Accurate diagnosis relies on a combination of clinical, histopathological, and immunopathological findings. Direct immunofluorescence (DIF) is a cornerstone in the diagnosis of AIBDs, as it enables visualization of in vivo-bound immunoreactants.
aimThis study aimed to assess the histopathological patterns and DIF findings among patients presenting with vesiculobullous lesions, focusing on the distribution, pattern, intensity, and type of antibody deposition.
methodsA total of 30 biopsy specimens from patients with clinically suspected vesiculobullous disorders were analyzed. Routine histopathology was performed, followed by DIF using anti-IgG, IgA, and C3 conjugates. Data on the pattern (linear basement membrane zone (BMZ) vs. intercellular (ICS)), intensity (weak, moderate, strong), and type of immunoglobulin deposition were recorded and analyzed.
resultsAmong the 30 cases, bullous pemphigoid (n=13) was the most common, followed by pemphigus vulgaris (n=5) and pemphigus foliaceous (n=4). DIF showed positivity in 20 cases (66.7%). Bullous pemphigoid exhibited a linear BMZ pattern with IgG and C3 deposition, showing moderate intensity in 10 and weak intensity in 3 cases. Pemphigus vulgaris and pemphigus foliaceous showed ICS IgG deposition, with pemphigus foliaceous also demonstrating weak IgA positivity. Granular C3 dermatosis showed BMZ C3 deposition with weak intensity. A highly significant association between IgG (p = 0.0001) and C3 (p = 0.002) positivity with specific histopathological diagnoses, while IgA showed no significant association (p = 0.987).
conclusionDIF is an invaluable diagnostic tool that complements histopathology, enabling accurate differentiation of AIBDs based on antibody type and distribution pattern. Other blistering conditions, including subcorneal pustules and acute inflammatory lesions, showed no or minimal immunoglobulin deposition. These findings highlight the diagnostic utility of DIF in differentiating AIBDs based on the type and intensity of antibody deposition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.